The impact of patient programmes is typically measured by the short-term increase in appropriate drug usage; this is a narrow measure of success. Patient programmes can create value in much broader terms by creating long-term change and supporting sustainable market access strategies.

This webinar will address this head-on.


The creation of value from patient programmes requires a good understanding of stakeholder desires. And then a pro-active implementation strategy. But how can you do this without adding huge complexity and cost to your marketing budget? How can you be sure that you're creating value for your company, throughout?


This webinar programme breaks down this new approach into 4 distinct areas, with expert guidance:

1. Patients: Latest examples of successful ways to support patients and boost compliance/adherence

2. Prescribers: Support of physicians and prescribers to help them meet their healthcare targets and make it easy for them to assist patients

3. Payers: Ways to prove to payors that your brands should be endorsed

4. Practical implementation: Examining the diversity of available patient programs and how to build outcomes into your strategy

1. Proven ways to improve patient compliance and support optimal health outcomes  

• Examine the broader impact of non-compliance beyond sales
• Take the concordance approach: identify and address the real reasons of non-compliance
• Learn from successful case studies and recent examples of best practice   

Debbie Robson, Programme Leader & Research Nurse in Medication Management, Kings College London

2. Prescribers and Physicians: support prescribers in the identification and management of patients onto the right therapy

Are Disease Management Programs (DMPs) finally a reality?

• Shifting health care paradigms
• What macro factors make disease management a reality?
• Key Success Factors; Who is playing what role?
• Who is to benefit and who is able to use DMP as a competitive advantage?
• Consider alternative prescriber models

Robert van der Zwart, Assistant Professor, Utrecht University (visiting), Director Business Development, Quadia

3. Payers: Demonstrate the value of your brand via patient programmes and advanced market access initiatives

• Make sure you have a clear picture of new and developing payer requirements: on national, regional and local levels
• Think beyond the initial creation of access …to maintain and improve prescriber's ability to choose your drugs
• How to continually demonstrate value through outcome data collection

Francesco Frattini, Business Development Director, Roche Italia

4. Make it Happen! Practical next steps

• With so many stakeholders and changing perspectives, how do you ‘keep it simple’, while ensuring you cover all the key elements required for a successful patient programme?
• What works best? Effective ways to measure impact, value and ROI?
• How to ensure a feedback loop to ensure results are fed into ongoing programme improvements

Morna Butler, Director, Global Health Management, Innovex